Advances in Treatment of PNH
In this webinar, Dr. Jaroslaw Maciejewski discusses the recent advances in treating PNH including treatments recently approved as well as what's in the pipeline. The recording includes the question and answer section.
family / friend
Spring MDS Update 2022
Cemdisiran (ALN-CC5)
Cemdisiran (ALN-CC5) is a subcutaneously administered, investigational RNAi therapeutic targeting the C5 component of the complement pathway in development for the treatment of complement-mediated diseases.
Pozelimab
Pozelimab is a monoclonal antibody inhibiting the pathway associated with haemolysis of red blood cells.
MDS to AML - 2022 San Antonio Patient & Family Virtual Conference
In this conference session, Dr. Amer Zeidan, MD discusses understanding the management options for higher risk MDS, the evolution of MDS to AML and more.
MDS/MPN Overlap - 2022 San Antonio Patient & Family Virtual Conference
In this conference session, Dr. Ruben Mesa, MD discusses the different features between MDS and MPN and their overlap syndromes.
PNH - 2022 San Antonio Patient &Family Virtual Conference
In this conference session, Dr. Anand Karnad, MD discusses best practices for treatment of PNH.
Management of Aplastic Anemia - 2022 San Antonio Patient &Family Virtual Conference
Living With Bone Marrow Failure Diseases - 2022 San Antonio Patient & Family Virtual Conference
In this conference session, Dr. Krisstina Gowin DO discusses best practices when living with bone marrow failure diseases.
The Rise of the Expert Patient in Cancer: From Backseat Passenger to Co-navigator
PURPOSE:
Patients who have cancer have leveraged the Internet to gain a better understanding of their disease and connect across geographic boundaries with others facing the same challenges. Online cancer communities have developed into resources that highlight new research and evolving care pathways. Combined with increasing health literacy and social media, they have enabled some patients to become experts in their cancer. This combination of empowerment and expertise describes the new “e-patients.”